These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4021230)

  • 21. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias].
    Ishii M; Komori S; Satoh H; Ohta T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):259-66. PubMed ID: 6149986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.
    Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K
    Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K; Tsukada T; Matsuda H; Nakagawa Y; Imai S
    J Cardiovasc Pharmacol; 1979; 1(2):205-17. PubMed ID: 94390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.
    Hashimoto K; Watanabe K; Mitsuhashi H
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmia models for drug research: classification of antiarrhythmic drugs.
    Hashimoto K
    J Pharmacol Sci; 2007 Apr; 103(4):333-46. PubMed ID: 17409630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of KRN2391 on canine ventricular arrhythmia models.
    Takeuchi A; Harada K; Miwa A; Jinno Y; Kaneta S; Yokoyama T; Ogawa N
    Gen Pharmacol; 1994 Jan; 25(1):53-60. PubMed ID: 8043150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a new forskolin derivative, NKH477, on canine ventricular arrhythmia models.
    Hirasawa A; Awaji T; Hosono M; Haruno A; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):847-51. PubMed ID: 7509903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K; Komori S; Ishii M; Kamiya J
    J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
    Takada K; Sumikawa K; Kamibayashi T; Hayashi Y; Yamatodani A; Kawabata K; Yoshiya I
    Anesthesiology; 1993 Sep; 79(3):563-70. PubMed ID: 8363083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
    Akiyama K; Hashimoto K
    Jpn Heart J; 1989 Jul; 30(4):487-95. PubMed ID: 2509760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
    Dimich I; Lingham R; Narang J; Sampson I; Shiang H
    Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Eur J Pharmacol; 2000 Jun; 398(1):107-12. PubMed ID: 10856454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
    Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
    Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bepridil, diltiazem and verapamil on atrial refractoriness and heart rate in the conscious dog: comparison with quinidine.
    Boucher M; Dubray C; Duchêne-Marullaz P
    Gen Pharmacol; 1991; 22(4):581-7. PubMed ID: 1936892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.